S2795 amends Rhode Island’s pesticide control law to add new definitions for rodenticides and related pest-management terms, and to create a phased restriction on anticoagulant rodenticide sales and use. Beginning March 1, 2027, first-generation anticoagulant rodenticides could no longer be sold in consumer retail outlets or online retail stores; beginning January 1, 2028, the same sales restriction would apply to second-generation anticoagulant rodenticides. Starting January 1, 2029, the use of both first- and second-generation anticoagulant rodenticides would be prohibited, subject to specified exceptions.
The bill also establishes a voluntary municipal Rodent Integrated Pest Management Pilot Program Act. Municipalities may designate rodent mitigation zones, conduct pre- and post-implementation inspections, track rodent signs and interventions, and report results to local officials and the Department of Environmental Management. The program is intended to test integrated pest management approaches that emphasize sanitation, environmental changes, natural predators, and other nonchemical methods, including rodent contraceptives where approved. The chapter would sunset on October 1, 2029 unless extended.
In terms of state law, the bill would add new sections to Chapter 23-25 and expand the regulatory framework governing pesticide distribution, certification, and use. It would restrict retail access to certain rodenticides, limit their use except in enumerated public health, medical waste, and agricultural settings, and authorize DEM to promulgate rules and administer an integrated pest management fund to support municipal pilot programs. The bill would therefore affect retailers, wholesalers, licensed applicators, municipalities, public health agencies, and agricultural operations that rely on rodent control products.
The general sentiment reflected in the bill text is precautionary and environmentally oriented, with a clear preference for integrated pest management and nonchemical rodent control over broad consumer access to anticoagulant rodenticides. Because there are no committee transcripts or recorded votes provided, there is no documented floor or committee debate to indicate broader political support or opposition. The structure of the bill suggests an attempt to phase in restrictions gradually while allowing limited exceptions for public health and certain commercial or agricultural uses.
Notable points of contention likely center on the practical impact of banning consumer sales and eventually use of anticoagulant rodenticides, especially for homeowners, retailers, pest-control businesses, and agricultural facilities. The bill’s exceptions for public health, drinking water protection, invasive species control, medical waste facilities, and certain food-production and beverage operations indicate an effort to balance environmental and wildlife concerns against operational needs. The pilot program and funding provisions also suggest that implementation costs, data collection burdens, and the effectiveness of nonchemical alternatives may be key issues.
The bill would amend Rhode Island’s Pesticide Control chapter to define first- and second-generation anticoagulant rodenticides and to prohibit their sale in consumer retail and online retail channels on a phased schedule, followed by a broader prohibition on use with specified exceptions. It would also create a new chapter authorizing voluntary municipal rodent integrated pest management pilot programs, establish reporting requirements, and create an integrated pest management fund administered by the Department of Environmental Management. The measure would directly affect pesticide retailers, applicators, municipalities, public health agencies, and certain agricultural and industrial facilities that use rodenticides.
The bill’s overall tone is supportive of reducing reliance on toxic rodenticides and promoting integrated pest management, with an emphasis on environmental protection, public health, and wildlife impacts. No committee testimony or vote history was provided, so there is no recorded evidence of formal support or opposition from legislators or stakeholders. The phased implementation and enumerated exceptions suggest the sponsor sought to make the policy more acceptable by allowing time for adjustment and preserving limited uses where necessary.
The main points of contention are likely the restrictions on consumer sales and eventual use of anticoagulant rodenticides, which could be viewed as burdensome by retailers, pest-control operators, and some property owners. Opponents may argue that the bill limits effective rodent-control tools, while supporters are likely to emphasize risks to humans, pets, and wildlife and the availability of nonchemical alternatives. The exceptions for public health, medical waste, and certain agricultural settings indicate that the bill attempts to address operational concerns, but those carveouts may also be a source of debate over whether the restrictions are too broad or too narrow.